Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Summary of the 2018–2019 Influenza Season Among Department of Defense Service Members and Other Beneficiaries

Image of 02_flu shot_DVIDS. A flu shot vaccination sits on a table at 184th Sustainment Command headquarters in Monticello, Mississippi on Feb. 8, 2020. The single best way to prevent seasonal flu is to get vaccinated each year, but good wellness habits like covering your cough and washing your hands often can help prevent the spread of germs. (Mississippi Army National Guard photo by Staff Sgt. Veronica McNabb)

What Are the New Findings?

The 2018–2019 influenza season was longer than the preceding 2 seasons. Unlike most prior seasons, 2 strains were common. Influenza A(H1N1)pdm09 was the most common strain early in the season, but influenza A(H3N2) predominated later in the season. Total influenza vaccine effectiveness was low during this season in part because the A(H3N2) strain was antigenically drifted from the vaccine strain.

What Is the Impact on Readiness and Force Health Protection?

Surveillance data about influenza disease inform the planning and strategy for efforts to reduce the future impact of influenza on the health and medical readiness of the Armed Forces. The data and findings in this report reinforce the importance of the use of up-to-date multivalent influenza vaccines that protect against several different specific virus strains that may become common in the coming influenza season.


The Armed Forces Health Surveillance Branch conducts weekly surveillance of influenza activity among Department of Defense (DOD) populations each influenza season. This report provides a summary of the data from the 2018–2019 influenza season. Ambulatory data for influenza-like illnesses (ILIs), influenza hospitalization data, and lab data for influenza-confirmed cases were used for the surveillance. The 2018–2019 season differed from past seasons in that it was much longer, had a later peak, and the predominant strain of influenza changed from influenza A(H1N1)pdm09 at the beginning of the season to influenza A(H3N2) in the middle of the season. Non-service member beneficiaries accounted for the majority of ILI-related encounters and hospitalizations. However, there were still 149 influenza-related hospitalizations among service members during the 2018–2019 season. Continued weekly surveillance of influenza among DOD populations is crucial to track increases in activity each season and the potential emergence of new and/or severe influenza subtypes.


Influenza infects an estimated 8% of the U.S. population annually, with children and the elderly at highest risk.1 Service members may also be at a higher risk for exposure to influenza because of increased crowding and mixing in the recruit setting and duty assignments abroad where influenza subtypes may differ.2 Each influenza season is different because of antigenic drift in the circulating influenza subtypes, the degree of match between vaccine subtypes and circulating subtypes, and vaccine coverage of the population. As such, it is important to conduct annual surveillance of each influenza season to identify the onset and patterns of activity, emergence of drifted or shifted subtypes, and severity of the season.

The Armed Forces Health Surveillance Branch of the Defense Health Agency utilizes electronic sources of ambulatory medical encounters, hospitalizations, and laboratory data to conduct annual influenza surveillance among all Department of Defense (DOD) beneficiaries across the world. Weekly reports are generated to provide near real-time influenza surveillance data for each of the DOD Combatant Commands. This report provides a summary of DOD influenza surveillance data for the 2018–2019 influenza season.


Medical encounter and demographic data from the Defense Medical Surveillance System (DMSS) and Health Level 7 (HL7)-formatted laboratory data from the Navy and Marine Corps Public Health Center (NMCPHC) were used for this analysis. The HL7-formatted laboratory data are non standardized, so NMCPHC applies an algorithm to the data to identify influenza tests and standardize results. The surveillance period for the 2018–2019 influenza season was 30 Sept. 2018 through 1 June 2019 (influenza weeks 40 through 22). Data from the 2016–2017 and 2017–2018 influenza seasons are also presented for comparison. The surveillance population included all individuals who were Military Health System (MHS) beneficiaries (i.e., active and reserve/guard component service members, retired service members, family members and other dependents of service members and retirees, and other authorized government employees and family members) who accessed care through either a military medical facility/provider or a civilian facility/provider (if paid for by the MHS). However, medical data from military treatment facilities (MTFs) that were using MHS GENESIS at the time of this surveillance (Naval Hospital Oak Harbor, Naval Hospital Bremerton, Air Force Medical Services Fairchild, and Madigan Army Medical Center) are not captured in the DMSS data. Therefore, medical encounter and laboratory data from these MTFs are not included in the analysis. For the analysis, populations were grouped as service members or other beneficiaries.

Outpatient medical encounters were classified as an influenza-like illness (ILI) encounter if they had an ILI diagnosis code (International Classification of Diseases, 10th Revision [ICD-10] codes B97.89, H66.9, H66.90, H66.91, H66.92, H66.93, J00, J01.9, J01.90, J06.9, J09, J09.X, J09.X1, J09.X2, J09.X3, J09.X9, J10, J10.0, J10.00, J10.01, J10.08, J10.1, J10.2, J10.8, J10.81, J10.82, J10.83, J10.89, J11, J11.0, J11.00, J11.08, J11.1, J11.2, J11.8, J11.81, J11.82, J11.83, J11.89, J12.89, J12.9, J18, J18.1, J18.8, J18.9, J20.9, J40, R05, R50.9) in any diagnostic position. The percentage of all outpatient encounters that were classified as ILI encounters was calculated for each week for each study population. Baseline ILI activity for the season was defined as the mean percentage of all outpatient encounters during non influenza weeks (weeks 22–39) over the prior 3 years.

Hospitalized influenza cases were defined as having a hospitalization with a diagnosis of influenza (ICD-10: J09, J10, J11) in any diagnostic position. The number of hospitalized influenza cases each week for each study population was calculated. For other beneficiaries, counts of influenza hospitalizations by age group (0–4, 5–9, 10–17, 18–35, 36–49, 50–64, 65+) were calculated.

Laboratory-confirmed influenza cases were defined as having a positive polymerase chain reaction, viral culture, or rapid influenza assay result. Laboratory-confirmed influenza cases were stratified by influenza types/subtypes (influenza A (not subtyped), influenza A(H1N1)pdm09, influenza A(H3N2), influenza A and B coinfection, and influenza B. The total number of laboratory-confirmed influenza cases stratified by type/subtype and the percentage of all influenza laboratory tests performed that had positive test results were calculated for each week of the influenza season for service members and for other beneficiaries separately.


Virus surveillance

Among all beneficiaries, there were 149,254 respiratory specimens tested for influenza during the 2018–2019 influenza season (data not shown). Of those, 30,464 (20.4%) were positive for influenza. Service members had a lower percentage of specimens testing positive for influenza (16.7%) compared to other beneficiaries (21.8%). Among all populations, influenza A (any subtype) predominated during this season, with 28,454 (93.4%) of all positive specimens testing positive for influenza A. The distribution of subtypes among influenza A positive specimens was 73.3% influenza A (not subtyped), 12.6% A(H3N2), and 7.5% A(H1N1)pdm09. The remaining specimens were positive for influenza B (1,805; 5.9%) or an influenza A/B coinfection (205; 0.7%). The distribution of subtypes was similar between service members and other beneficiaries (data not shown).

The distribution of influenza serotypes and the percentage of specimens positive for influenza by week are presented in Figures 1a and 1b for service members and other beneficiaries, respectively. Among subtyped influenza A specimens, A(H1N1) pdm09 predominated early in the season, but A(H3N2) was predominant after week 3. The highest numbers of positive specimens and the highest percentages of positives occurred during week 9 for service members and weeks 6 and 7 for other beneficiaries. These results indicate peak influenza activity for the season during the month of Feb. 2019.

Outpatient encounter ILI surveillance

During the 2018–2019 season, the weekly percentages of outpatient encounters due to an ILI for service members were above baseline (2.1%) for 22 weeks (weeks 46–15) (Figure 2a). A similar pattern was seen among other beneficiaries, for whom the percentages were above baseline (3.4%) for 20 weeks (weeks 47–14) (Figure 2b). This pattern is similar to the percentage of outpatient encounters due to ILI during the prior 2 influenza seasons.

Earlier in the 2018–2019 season, between weeks 40–52, the trend and magnitude of the percentages of encounters due to ILI were also similar to those of the past 2 seasons (Figures 2a and 2b). All seasons had peaks during weeks 52 and 1. This timing coincides with the end-of-year holiday period. Rather than a true peak in ILI activity though, this peak was being driven by a differential decrease in the total number of medical encounters and ILI encounters during that time. Specifically, for the 2018–2019 season, the total number of outpatient medical encounters decreased 58% from week 51 to week 52; however, ILI encounters decreased only 36% between those 2 weeks. Therefore, this peak in ILI percentage is considered an artifact of the overall decline in total outpatient encounters and is not reflected in the peak influenza weeks for the season. After week 1, the 2018–2019 season ILI percentages began to diverge from the prior 2 seasons. Among service members, the percentage of encounters due to ILI had a later peak (week 8) than the prior 2 seasons (weeks 2 and 3), but the magnitude of the 2018–2019 peak was similar to that of the 2017–2018 peak (Figure 2a). Among other beneficiaries, the trend was similar to the 2 prior seasons, with peak activity occurring during week 6 (2017–2018: week 5; 2016–2017: week 6), and the magnitude was similar to the 2016–2017 season (Figure 2b).

Influenza-related hospitalizations

Of the total 5,847 influenza-related hospitalizations during the 2018–2019 season, 149 occurred among service members (Figure 3). The majority of hospitalizations occurred among other beneficiaries (n=5,698; 97.5%). Hospitalizations peaked overall during week 11 (n=471), but service member hospitalizations peaked during week 10 (n=18) (Figure 3). Among other beneficiaries, the majority of influenza-related hospitalizations occurred among those 65 years of age or older (n=3,778; 66.3%) (Figure 4).

Editorial Comment

The 2018–2019 influenza season among service members and other DOD beneficiaries was a longer season with a later peak compared to the prior 2 seasons. The season also differed from prior seasons in that the beginning of the season was predominated by influenza A(H1N1)pdm09 while influenza A(H3N2) predominated after week 3; most seasons have just 1 influenza A subtype predominating. As expected, the influenza season among DOD service members and beneficiaries was similar to the season among the general U.S. population.3 Although the DOD influenza surveillance data include information from around the world, the majority of encounter and laboratory data came from the U.S. and to a lesser extent Europe, which also had an influenza season similar to that in the U.S.4 As with the general U.S. population, the elderly (> 64 years of age) accounted for the majority of influenza hospitalizations among other beneficiaries. The elderly population accounted for 66% of all other beneficiary hospitalizations for the season compared to 47% among the general U.S. population.3

A seasonal influenza vaccine is still the best way to protect against influenza. Service members are required to receive a seasonal influenza vaccine annually. During the 2018–2019 season, DOD policy set a goal of 90% of service members vaccinated by 15 Jan. 2019.5 Although vaccination rates of service members were very high, influenza cases still occurred among this population during the 2018–2019 season. Cases of influenza among service members may be attributable to infections occurring before receipt of the influenza vaccine, within the 14 days following vaccination when the vaccine may not provide complete protection, or after vaccination because the vaccine is less than 100% effective. During the 2018–2019 season, vaccine effectiveness among the general U.S. population was particularly low because of the emergence of a drifted A/H3N2 (clade 3C.3a) circulating virus that differed from the vaccine strain.6 Although the influenza vaccine is not 100% effective at preventing influenza infection, a recent study showed that vaccination also decreased the risk of hospitalization and admission to the intensive care unit and decreased severity of illness.7 Continued vaccination of service members and other DOD beneficiaries is crucial to combat influenza infections and lessen disease severity. This season also demonstrated the importance of annual influenza surveillance, as the seasons differ from year to year.


  1. Tokars JI, Olsen SJ, Reed C. Seasonal incidence of symptomatic influenza in the United States. Clin Infect Dis. 2018;66(10):1511–1518.
  2. Sanchez JL, Cooper MJ. Influenza in the US military: an overview. J Infec Dis Treat. 2016;2(1).
  3. Xu X, Blanton L, Elal AIA, et al. Update: Influenza activity in the United States during the 2018–19 season and composition of the 2019–20 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2019;68(24):544–551.
  4. European Centre for Disease Prevention and Control. Weekly influenza update, week 20, May 2019. Accessed 28 Jan. 2020.
  5. Department of Defense Assistant Secretary of Defense. Memorandum: Guidance for the 2018–2019 Annual Influenza Immunization Program. 05 July 2018.
  6. Flannery B, Kondor RJG, Chung JR, et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018–2019 season. J Infect Dis. 2020;221(1):8–15.
  7. Thompson MG, Pierse N, Sue Huang Q, et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine. 2018;36(39):5916–5925.


FIGURE 1a. Numbers of laboratory-confirmed influenza specimens by serotype and percentages of respiratory specimens positive for influenza by surveillance week, service members, U.S. Armed Forces, 2018–2019 influenza season

FIGURE 1b. Numbers of laboratory-confirmed influenza specimens by serotype and percentages of respiratory specimens positive

FIGURE 2a. Percentages of outpatient encounters due to ILI, service members, U.S. Armed Forces, 2018–2019 influenza season

FIGURE 2b. Percentages of outpatient encounters due to ILI, other DoD beneficiaries, 2018–2019 influenza season

IGURE 3. Influenza-related hospitalizations, service members and other DoD beneficiaries, 2018–2019 influenza season

FIGURE 4. Age distribution of beneficiaries with influenza-related hospitalizations, 2018–2019 influenza season

You also may be interested in...

Vasectomy and Vasectomy Reversals, Active Component, U.S. Armed Forces, 2000–2017

Sperm is the male reproductive cell  Photo: iStock

During 2000–2017, a total of 170,878 active component service members underwent a first-occurring vasectomy, for a crude overall incidence rate of 8.6 cases per 1,000 person-years (p-yrs). Among the men who underwent incident vasectomy, 2.2% had another vasectomy performed during the surveillance period. Compared to their respective counterparts, the overall rates of vasectomy were highest among service men aged 30–39 years, non-Hispanic whites, married men, and those in pilot/air crew occupations. Male Air Force members had the highest overall incidence of vasectomy and men in the Marine Corps, the lowest. Crude annual vasectomy rates among service men increased slightly between 2000 and 2017. The largest increases in rates over the 18-year period occurred among service men aged 35–49 years and among men working as pilots/air crew. Among those who underwent vasectomy, 1.8% also had at least 1 vasectomy reversal during the surveillance period. The likelihood of vasectomy reversal decreased with advancing age. Non-Hispanic black and Hispanic service men were more likely than those of other race/ethnicity groups to undergo vasectomy reversals.

Testosterone Replacement Therapy Use Among Active Component Service Men, 2017


This analysis summarizes the prevalence of testosterone replacement therapy (TRT) during 2017 among active component service men by demographic and military characteristics. This analysis also determines the percentage of those receiving TRT in 2017 who had an indication for receiving TRT using the 2018 American Urological Association (AUA) clinical practice guidelines. In 2017, 5,093 of 1,076,633 active component service men filled a prescription for TRT, for a period prevalence of 4.7 per 1,000 male service members. After adjustment for covariates, the prevalence of TRT use remained highest among Army members, senior enlisted members, warrant officers, non-Hispanic whites, American Indians/Alaska Natives, those in combat arms occupations, healthcare workers, those who were married, and those with other/unknown marital status. Among active component male service members who received TRT in 2017, only 44.5% met the 2018 AUA clinical practice guidelines for receiving TRT.

Update: Malaria, U.S. Armed Forces, 2018

Anopheles merus

Malaria infection remains an important health threat to U.S. service mem­bers who are located in endemic areas because of long-term duty assign­ments, participation in shorter-term contingency operations, or personal travel. In 2018, a total of 58 service members were diagnosed with or reported to have malaria. This represents a 65.7% increase from the 35 cases identi­fied in 2017. The relatively low numbers of cases during 2012–2018 mainly reflect decreases in cases acquired in Afghanistan, a reduction due largely to the progressive withdrawal of U.S. forces from that country. The percentage of cases of malaria caused by unspecified agents (63.8%; n=37) in 2018 was the highest during any given year of the surveillance period. The percent­age of cases identified as having been caused by Plasmodium vivax (10.3%; n=6) in 2018 was the lowest observed during the 10-year surveillance period. The percentage of malaria cases attributed to P. falciparum (25.9 %) in 2018 was similar to that observed in 2017 (25.7%), although the number of cases increased. Malaria was diagnosed at or reported from 31 different medical facilities in the U.S., Afghanistan, Italy, Germany, Djibouti, and Korea. Pro­viders of medical care to military members should be knowledgeable of and vigilant for clinical manifestations of malaria outside of endemic areas.

Update: Incidence of Glaucoma Diagnoses, Active Component, U.S. Armed Forces, 2013–2017


Glaucoma is an eye disease that involves progressive optic nerve damage and vision loss, leading to blindness if undetected or untreated. This report describes an analysis using the Defense Medical Surveillance System to identify all active component service members with an incident diagnosis of glaucoma during the period between 2013 and 2017. The analysis identified 37,718 incident cases of glaucoma and an overall incidence rate of 5.9 cases per 1,000 person-years (p-yrs). The majority of cases (97.6%) were diagnosed at an early stage as borderline glaucoma; of these borderline cases, 2.2% progressed to open-angle glaucoma during the study period. No incident cases of absolute glaucoma, or total blindness, were identified. Rates of glaucoma were higher among non-Hispanic black (11.0 per 1,000 p-yrs), Asian/Pacific Islander (9.5), and Hispanic (6.9) service members, compared with non-Hispanic white (4.0) service members. Rates among female service members (6.6 per 1,000 p-yrs) were higher than those among male service members (5.8). Between 2013 and 2017, incidence rates of glaucoma diagnoses increased by 75.4% among all service members.

Re-evaluation of the MSMR Case Definition for Incident Cases of Malaria

Anopheles merus

The MSMR has been publishing the results of surveillance studies of malaria since 1995. The standard MSMR case definition uses Medical Event Reports and records of hospitalizations in counting cases of malaria. This report summarizes the performance of the standard MSMR case definition in estimating incident cases of malaria from 2015 through 2017. Also explored was the potential surveillance value of including outpatient encounters with diagnoses of malaria or positive laboratory tests for malaria in the case definition. The study corroborated the relative accuracy of the MSMR case definition in estimating malaria incidence and provided the basis for updating the case definition in 2019 to include positive laboratory tests for malaria antigen within 30 days of an outpatient diagnosis.

Outbreak of Acute Respiratory Illness Associated with Adenovirus Type 4 at the U.S. Naval Academy, 2016

Malaria case definition

Human adenoviruses (HAdVs) are known to cause respiratory illness outbreaks at basic military training (BMT) sites. HAdV type-4 and -7 vaccines are routinely administered at enlisted BMT sites, but not at military academies. During Aug.–Sept. 2016, U.S. Naval Academy clinical staff noted an increase in students presenting with acute respiratory illness (ARI). An investigation was conducted to determine the extent and cause of the outbreak. During 22 Aug.–11 Sept. 2016, 652 clinic visits for ARI were identified using electronic health records. HAdV-4 was confirmed by real-time polymerase chain reaction assay in 18 out of 33 patient specimens collected and 1 additional HAdV case was detected from hospital records. Two HAdV-4 positive patients were treated for pneumonia including 1 hospitalized patient. Molecular analysis of 4 HAdV-4 isolates identified genome type 4a1, which is considered vaccine-preventable. Understanding the impact of HAdV in congregate settings other than enlisted BMT sites is necessary to inform discussions regarding future HAdV vaccine strategy.

Thyroid Disorders, Active Component, U.S. Armed Forces, 2008–2017

Cover 1

This analysis describes the incidence and prevalence of five thyroid disorders (goiter, thyrotoxicosis, primary/not otherwise specified [NOS] hypothyroidism, thyroiditis, and other disorders of the thyroid) among active component service members between 2008 and 2017. During the 10-year surveillance period, the most common incident thyroid disorder among male and female service members was primary/NOS hypothyroidism and the least common were thyroiditis and other disorders of thyroid. Primary/NOS hypothyroidism was diagnosed among 8,641 females (incidence rate: 43.7 per 10,000 person-years [p-yrs]) and 11,656 males (incidence rate: 10.2 per 10,000 p-yrs). Overall incidence rates of all thyroid disorders were 3 to 5 times higher among females compared to males. Among both males and females, incidence of primary/NOS hypothyroidism was higher among non-Hispanic white service members compared with service members in other race/ethnicity groups. The incidence of most thyroid disorders remained stable or decreased during the surveillance period. Overall, the prevalence of most thyroid disorders increased during the first part of the surveillance period and then either decreased or leveled off.31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

Adrenal Gland Disorders, Active Component, U.S. Armed Forces, 2002–2017

During 2002–2017, the most common incident adrenal gland disorder among male and female service members was adrenal insufficiency and the least common was adrenomedullary hyperfunction. Adrenal insufficiency was diagnosed among 267 females (crude overall incidence rate: 8.2 cases per 100,000 person-years [p-yrs]) and 729 males (3.9 per 100,000 p-yrs). In both sexes, overall rates of other disorders of adrenal gland and Cushing’s syndrome were lower than for adrenal insufficiency but higher than for hyperaldosteronism, adrenogenital disorders, and adrenomedullary hyperfunction. Crude overall rates of adrenal gland disorders among females tended to be higher than those of males, with female:male rate ratios ranging from 2.1 for adrenal insufficiency to 5.5 for androgenital disorders and Cushing’s syndrome. The highest overall rates of adrenal insufficiency for males and females were among non-Hispanic white service members. Among females, rates of Cushing's syndrome and other disorders of adrenal gland were 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

Incidence and Prevalence of the Metabolic Syndrome Using ICD-9 and ICD-10 Diagnostic Codes, Active Component, U.S. Armed Forces, 2002–2017

This report uses ICD-9 and ICD-10 codes (277.7 and E88.81, respectively) for the metabolic syndrome (MetS) to summarize trends in the incidence and prevalence of this condition among active component members of the U.S. Armed Forces between 2002 and 2017. During this period, the crude overall incidence rate of MetS was 7.5 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, overall incidence rates were highest among Asian/Pacific Islanders, Air Force members, and warrant officers and were lowest among those of other/unknown race/ethnicity, Marine Corps members, and junior enlisted personnel and officers. During 2002–2017, the annual incidence rates of MetS peaked in 2009 at 11.6 cases per 100,000 p-yrs and decreased to 5.9 cases per 100,000 p-yrs in 2017. Annual prevalence rates of MetS increased steadily during the first 11 years of the surveillance period reaching a high of 38.9 per 100,000 active component service members in 2012, after which rates declined slightly to 31.6 per 100,000 active component service members in 2017. Validation of ICD-9/ICD-10 diagnostic codes for MetS using the National Cholesterol Education Program Adult Treatment Panel III criteria is needed to establish the level of agreement between the two methods for identifying this condition.

Page 14 of 14 , showing items 196 - 204
First < ... 11 12 13 14 > Last 
Refine your search
Last Updated: October 24, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery